About

Eric Chappel joined Debiotech in 2003 as an R&D Engineer and was appointed as an R&D Project Manager in 2004. Prior to Debiotech, Dr Chappel developed and industrialised the backend process of optical MEMS at Memscap. His research interests are innovative medical devices, including insulin micropumps, hydrocephalus shunts, implantable pumps and wearable injectors. He received an MSc in Physics in 1996 from the Université Grenoble Alpes (Grenoble, France) and achieved his PhD in Condensed Matter Physics at the French National High Magnetic Field Laboratory (Grenoble, France) in 2000.

Contributions

PREFILLED SYRINGES

LOW-COST DISPOSABLE WEARABLE INJECTOR PLATFORM FOR LARGE VOLUMES OF VISCOUS DRUGS

Eric Chappel, Dimitry Dumont-Fillon and Laurent-Dominique Piveteau discuss Debiotech’s novel wearable injector technology, which utilises a propellant vapour system to drive the injection, making the device both space- and cost-efficient.